Scott W Woods MD

Professor, Psychiatry, Yale University School of Medicine

34 Park St# ConnectiNew Haven, CT 06519
Phone+1 203-974-7417
Fax+1 203-974-7413

Dr. Woods is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Woods' full profile Already have an account?

Education & Training

Mass General Brigham/Massachusetts General Hospital/McLean HospitalResidency, Psychiatry, 1980 - 1984
Baylor College of MedicineClass of 1978

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

CT State Medical License 1984 - 2027
TX State Medical License 1979 - 1984
American Board of Psychiatry and Neurology Psychiatry

Clinical Trials

Rapid Benzodiazepine Detoxification Using Flumazenil - 1
COMPLETED
PHASE2
Treatment of Panic Disorder: Long Term Strategies
COMPLETED
PHASE3
Prevalence of Diabetes Mellitus Among Patients Treated With Atypical and Conventional Antipsychotics
COMPLETED

Publications & Presentations

PubMed

Comparative profiles of anomalous self-experiences and social cognition in clinical high risk for psychosis and autism spectrum disorder.
Kristina Ballestad Gundersen, Tina Dam Kristensen, Alberte C E Jeppesen, Johannes Andresen, Helle Gade Andersen
Schizophrenia Research. Cognition. 2026-09-01
Right hippocampal volume and attenuated psychotic symptoms distinguish subgroups of youth with common patterns of temporoparietal effective connectivity.
Katrina Aberizk, Benson S Ku, Hengyi Cao, Charles H Schleifer, Jean M Addington
Brain Structure & Function. 2026-08-08
Large language models can supplement the assessment of clinical high risk for psychosis.
Luz Maria Alliende, Rob Voigt, Maeve Hoffman, Gregory P Strauss, Lauren M Ellman
Journal of Psychopathology and Clinical Science. 2026-08-06

Journal Articles

Use of Machine Learning to Determine Deviance in Neuroanatomical Maturity Associated with Future Psychosis in Youths at Clinically High Risk
Daniel H Mathalon, Thomas McGlashan, Scott W Woods, Diana Perkins, Ming Tsuang, Carrie E Bearden, Kristin Cadenhead, JAMA

Press Mentions

‘The Pitt’ Is Showing Us the Complicated Reality of PsychosisFebruary 26th, 2026
Feinstein Institutes Researchers Help Lead $52M Study of Schizophrenia in High-Risk YouthNovember 16th, 2020
Accelerating Science to Advance Early Interventions for SchizophreniaOctober 30th, 2020

Grant Support

ProCAN: Psychosis Risk Outcomes Compound Assessment NetworkYALE UNIVERSITY2024–2029
ProCAN: Psychosis Risk Outcomes Compound Assessment NetworkYALE UNIVERSITY2024–2029
ProCAN: Psychosis Risk Outcomes Compound Assessment NetworkYALE UNIVERSITY2024–2029
ProCAN: Psychosis Risk Outcomes Compound Assessment NetworkYALE UNIVERSITY2024–2029
DDT-COA-000-163 Accelerating the FDA COA Qualification Package for thePSYCHS as a ClinRO measureYALE UNIVERSITY2025–2027